Story at a glance
- Reuters reports the CDC on Tuesday said one case occurred in a male and another in a female vaccine recipient, both under the age of 60.
- That brings the total number of such cases to 17 out of the more than 8 million of the single-dose shots that have been administered in the U.S.
- Health regulators say instances of severe blood clots linked to the vaccine are extremely rare and that the shot’s benefits outweigh its risks.
The Centers for Disease Control and Prevention (CDC) is investigating two new cases of rare blood clots followed by the administration of Johnson & Johnson’s COVID-19 vaccine.
Reuters reports the health agency on Tuesday said one case occurred in a male and another in a female vaccine recipient, both under the age of 60, bringing the total number of such cases to 17 out of the more than 8 million of the single-dose shots that have been administered in the U.S.
Our country is in a historic fight against the Coronavirus. Add Changing America to your Facebook or Twitter feed to stay on top of the news.
The two new cases come as U.S. regulators late last week said Johnson & Johnson coronavirus vaccinations can resume immediately after a federal advisory panel concluded that the shot’s benefits outweigh its risk. The Johnson & Johnson vaccine will now be accompanied by a new warning on its label about the possibility of the blood clots.
A temporary pause was placed on the national rollout of the vaccine earlier this month as federal authorities investigated the extremely rare, severe blood clotting syndrome that may be linked to the jab.
“This adverse event is rare, occurring at a rate of about 7 per 1 million vaccinated women between 18 and 49 years old,” the CDC said in new guidance posted this week. “For women 50 years and older and men of all ages, this adverse event is even more rare.”
But a recent poll suggests confidence in the shot has fallen among the public following the temporary pause. A Washington Post-ABC News poll released this week found fewer than 1 in 4 Americans who have yet to be vaccinated against COVID-19 say they would be willing to get the single-dose vaccine.
READ MORE STORIES FROM CHANGING AMERICA
PFIZER-BIONTECH BOOSTER LIKELY NEEDED AS IMMUNITY WANES, SAYS SCIENTIST WHO HELPED DEVELOP VACCINE
AFTER CALLING IT A SCAM, CONTROVERSIAL ROCKER TED NUGENT CONTRACTS COVID-19
COMPANY AWARDED MILLIONS BY TRUMP TO MAKE VACCINE SYRINGES HAS NOT MADE EVEN ONE
FEWER THAN 6,000 PEOPLE HAVE GOTTEN COVID-19 AFTER BEING FULLY VACCINATED, SAYS CDC
Copyright 2023 Nexstar Media Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
